Considered together, these results indicated that DDX56 enhances MIST1 transcription by recruiting MECOM to mono-methylate H3K9 on the MIST1 promoter, which subsequently activates the PTEN-AKT pathway to promote HCC proliferation. The gene discussed is MECOM; the disease is hepatocellular carcinoma.